Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2
Mohit Chhabra(The University of Queensland), Vito Ferro(The University of Queensland), Chethan D. Shanthamurthy(Indian Institute of Science Education and Research Pune), Raghavendra Kikkeri(Indian Institute of Science Education and Research Pune), James J. De Voss(The University of Queensland), Alberto A. Amarilla(Commonwealth Scientific and Industrial Research Organisation), Daniel Watterson(The University of Queensland), Norbert Wimmer(The University of Queensland), Israël Vlodavsky(Technion – Israel Institute of Technology), Sandhya Mardhekar(Indian Institute of Science Education and Research Pune), Raymond A. Smith(The University of Queensland), Yasmin Kayal(Technion – Israel Institute of Technology), Neha S. Gandhi(Queensland University of Technology), Naphak Modhiran(The University of Queensland), Lauren R. Dorsett(Queensland University of Technology), Sharath S. Vishweshwara(Indian Institute of Science Education and Research Pune), Nanjudaswamy Vijendra Kumar(Indian Institute of Science Education and Research Pune), James R. Beckett(The University of Queensland)
Cited by 7
Related Papers
A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane.
|PubMed|1988|877
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
|Molecular Psychiatry|2022|178
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses
|Nature Communications|2021|177
Heparan Sulfate Is a Cellular Receptor for Purified Infectious Prions
|Journal of Biological Chemistry|2005|175
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models
|British Journal of Cancer|2011|165